| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  REGEMAT 3D Customized Bioprinting systems and Bioreactors REGEMAT3D develops customized Bioprinting Systems and Bioreactors - BMAP. We create Living Tissue Technologies. The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration. Our mission is to develop innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, to improve people ́s quality of life. bioprinting, regenerative medicine, biotechnology, and tissue engineering Type: | 3 | 0 | 1 | 22 |
 | Aptamer Group We develop Optimer® binders to enable innovation across the life science industry. Aptamer Group develops Optimer® binders to enable innovation in the life science industry. Get our newsletter: https://aptamergroup.com/newsletter Research and Development, Assay Development, Custom development, Drug development, Custom reagents, Agriculture testing, Aptamers, Biomarker discovery, Affinity ligands, Environmental testing, Affinity chromatography ligands, ADCs / AOCs, QC reagents, Diagnostic tools, and Targeted delivery Type: | 3 | 0 | 3 | 41 |
 | Colorifix Unlocking nature's pigments for the global dyeing industry We bring colour to life. Colorifix has developed a revolutionary dyeing process to help the textile industry dramatically reduce its environmental impact in a cost-effective manner. Using synthetic biology we produce, deposit and fix dyes biologically, avoiding harmful chemicals whilst reducing water, energy and waste. Let's rethink industrial dyeing. Contact us today to discuss how Colorifix can fulfil your coloration requirements. Type: | 9 | 3 | 8 | 92 |
 | Medherant Limited Medherant is a clinical-stage company developing innovative treatments using its novel transdermal drug delivery technology, the TEPI Patch, which is based on a proprietary adhesive developed by its scientists. The Company was founded by Professor David Haddleton and the University of Warwick in 2015 based on their world-leading expertise in bioadhesives and polymer chemistry. The adhesive has a high drug loading capacity, so a smaller quantity of adhesive is needed to deliver a therapeutic dose; the patch can therefore be thinner and more flexible. It also enables excipients, such as permeation enhancers, to be included in the adhesive so the … Type: | 2 | 0 | 1 | 16 |
 | TrakCel Transforming Cellular Orchestration for Cell & Gene Therapy. Join us. See the journey. TrakCel design, deploy and support digital Cellular Orchestration Solutions that track and manage all the components of the Cell and Gene Therapy supply chain, helping therapy developers to deliver therapies to patients safely and efficiently for both clinical and commercial stage therapies. For each Advance Therapy Patient journey, from sample collection through logistics, manufacturing and final treatment, TrakCel's flagship platform, OCELLOS orchestrates every step, providing a comprehensive chain of custody, chain of identity and traceability throughout. Always remembering there is a patient at the end of everything … Type: | 2 | 0 | 2 | 92 |
 | PBD Biotech PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection. PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection. One quarter of the world’s population is infected with latent tuberculosis (LTBI), also known as inactive tuberculosis. One in ten people with LTBI will progress to active TB disease. It is essential to develop newer diagnostic tests with significantly increased predictive value for the development of active disease among those who are infected than the currently available tests for LTBI (WHO, 2017). At PBD Biotech, our mission is to support the scale-up of latent … Type: | 8 | 1 | 3 | 15 |
 | Neumora Pioneering a new era of medicines for brain diseases Brain diseases collectively represent one of the largest areas of unmet medical need, affecting upwards of 1.5 billion patients globally. Neumora was founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our goal is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients. We’ve built a pipeline comprised of programs for neuropsychiatric disorders and neurodegenerative diseases, each targeting a novel mechanism … Type: | 1 | 0 | 1 | 130 |
 | Biotrains CONNECT COLLABORATE EVOLVE Biotrains is world's leading provider of business conferences, training, managed events and Consulting services for Pharmaceutical, Biotech, Healthcare and Medical Device industry. We at Biotrains recognize that knowledge is power and continuous learning is fundamental for the success of all business and academia. We deliver world-class content and expert knowledge that our clients demand to outshine in their professional roles giving a competitive advantage to their organization. We organize specialized technical events in areas including • Lyophilization/Freeze Drying • Bioprocess Development & Manufacturing • Drug Development, Drug Discovery • Diagnostics & Personalized Medicine • Healthcare, Home Healthcare … Type: | 4 | 0 | 4 | 36 |
 |  Béa Fertility Startup building the first clinical grade fertility treatment | Increasing access to effective and affordable treatments The future of fertility care is here. Affordable, at-home ICI-based fertility treatment designed to help you get you pregnant. Fertility and Medical Device Type: | 3 | 0 | 2 | 23 |
 | Bicycle Therapeutics Bicycle Precision Guided Therapeutics. Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTCTM) targeting EphA2; BT8009, a second-generation BTC targeting Nectin-4, a well-validated tumor antigen; and BT7480, a Bicycle TICATM targeting Nectin-4 and agonizing CD137, … Type: | 6 | 2 | 1 | 272 |
 |  Cellesce Ltd Cellesce specialises in the development, scale up and manufacture of PDOs (patient-derived organoids) Cellesce Ltd is a biochemical engineering company based in Cardiff in the UK. Cellesce specialises in the development, scale up and manufacture of organoids (PDOs). Cell expansion, Organoid culture, Drug discovery, Oncology, Bioprocess, and 3D Cell Culture Type: | 2 | 0 | 0 | 4 |
 | Cumulus Neuroscience Accelerating CNS Clinical Trials We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience. Type: | 4 | 0 | 3 | 41 |
 | Kanabo Built for Better Health - Get treatment for Pain management and Mental Health here: https://treat-it.clinic - See a GP Online here: https://thegpservice.co.uk - Shop Kanabo here: https://kanabo.store Kanabo Group plc (LSE:KNB) is a digital health company committed to transforming patient care through its innovative technology platform and specialised treatment offerings. Since its inception, Kanabo has been focused on researching, developing, and commercialising regulated medicinal cannabis-derived formulations and therapeutic inhalation devices. Kanabo's NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services. Leveraging its telehealth capabilities, in 2023, Kanabo launched Treat It, an … Type: | 0 | 0 | 0 | 16 |
 | LabGenius Combining human and machine intelligence to accelerate the discovery of advanced medicines. LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVATM). Our protein engineering platform integrates several bleeding edge technologies from the fields of machine learning, synthetic biology and robotics. Synthetic Biology, Protein Engineering, Artificial Intelligence, Machine Learning, High Throughput Screening, Medical, Health, DNA Libraries, drug discovery, and protein therapeutics Type: | 7 | 0 | 5 | 59 |
 | MediSieve Novel Biotech dual-platform: therapeutic and drug-delivery MediSieve is a London biotech start-up developing Magnetic Haemofiltration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients. It can be used (1) as a direct treatment, (2) to increase the safety and efficacy of other therapies, or (3) to enable personalised medicine. A unique, lifesaving and often cost-saving solution, there are several multi-billion-dollar markets available for this product in oncology, infectious diseases, auto-immune diseases, poisoning, drug overdose and others. Magnetic Haemofiltration has already been shown to rapidly, specifically, and effectively remove IL-6 from human plasma. … Type: | 12 | 1 | 12 | 14 |
 | Abingdon Health plc Improving life by making rapid results accessible to all. Lateral flow test development, manufacture & commercialisation We are lateral flow CDMO experts based in the UK supporting global customers bring their assays to market, from proof of concept, through optimisation and scale up to routine manufacture, along with full-service regulatory consultancy support. Get in touch: email info@abingdonhealth.com today. We believe that by developing the high quality, effective lateral flow rapid tests combined with our manufacturing experience and scale, we can provide the means to accelerate access to rapid testing. This means faster diagnosis and screening in the field, accelerating the … Type: | 5 | 0 | 3 | 73 |
 | Microbiotica Microbiotica identifies gut bacteria linked to phenotype with unprecedented precision in order to discover and develop live bacterial therapeutics and biomarkers from clinical datasets. Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products. Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics … Type: | 5 | 1 | 1 | 56 |
 | CN Bio Generate human-specific efficacy and safety data with PhysioMimix® Single- and Multi-organ microphysiological systems. CN Bio is a leading organ-on-a-chip (OOC) company that enables researchers to improve the accuracy and efficiency of preclinical drug discovery. Our PhysioMimix® suite of microphysiological systems, 3D-validated cells, consumable plates, and Contract Research Services facilitate the prediction of human responses to drug exposure, in the presence or absence of disease, so that new medicines can be brought to market more rapidly, cost-effectively and using fewer animals. Utilizing primary cells, our perfused single (Lung, Liver), and multi-organ (Intestine/Liver, Lung/Liver) models recapitulate the microarchitecture, microenvironment and function of … Type: | 4 | 2 | 4 | 47 |
 | CYNBIOSE Exploring together! We support biopharmaceutical research with translational preclinical models. CYNBIOSE is France-based non-clinical research organization. Preclinical CRO, Pharmacokinetics, POC, Efficacy, Immunotherapies, Drug, Early tox, CNS, Infectious diseases, Respiratory diseases, Non clinical, CRO, PK, PD, and TK Type: | 7 | 3 | 4 | 17 |
 | Nosopharm Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR). The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs. The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus. Anti-Infectives, Drug Discovery, Antibiotics, and Microbiology Type: | 12 | 10 | 2 | 7 |
 | HEALTIS "Where MRI meets Safety" HEALTIS is an experienced MRI safety and compatibility company located in Nancy, France. We are ISO/IEC 17025 accredited* and provide expert services in the following fields: • MRI Safety and Compatibility Assessment of Medical Devices (MRI safety testing laboratory) • Numerical Modeling • MRI Safety and Compatibility Training • Technical and Regulatory Support related to MRI Safety and Compatibility We perform tests in compliance with the following international standards: ASTM F2052 · ASTM F2213 · ASTM F2182 · ASTM F2119 · ASTM F2503 · ISO/TS 10974; and are an active participant in international normative groups. Additionally, … Type: | 3 | 1 | 0 | 16 |
 | X'PROCHEM We produce customised chemical proteins to help our bio-pharms partners to accelerate their projects. 🧪 X’PROCHEM is a biotech company who invented an advanced and proprietary ligation technology. We help our bio-pharma partners design and create therapeutic, vaccine and diagnostic proteins. Unlike recombinant fermentation we can produce proteins containing up to 400 amino acids, without isoforms, endotoxins, or biological contaminants. We co develop solutions with our partners to understand the real needs within the context. By working closely, we can adapt to changing needs and circumstances. protein, purification, synthesis, protein production, peptide synthesis, and life sciences Type: | 1 | 0 | 1 | 14 |
 | NEURO-SYS CNS/PNS - In vitro - In vivo - Drug Development Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields. We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. Our expertise: › Alzheimer’s disease (AD) › Parkinson’s … Type: | 0 | 0 | 0 | 30 |
 | Miravas Miravas is an innovative medical devices start up in varicose veins treatment Soon a new device for the treatment of venous disease in medical office setting, with combination of two complementary techniques, steam and radiofrequency Varicose veins treatment, Medical devices, and Thermal ablation Type: | 0 | 0 | 0 | 0 |
 | Inoviem Scientific Creative Technologies for Efficient Therapeutics, Precision medicine Inoviem is a Biotech and Bioanalytical company, which is supporting Pharma and Biotech companies in achieving their goals in both preclinical and clinical development by optimizing time and resources in the entire drug discovery process. Inoviem reconciles Technology and Physiology with a Patient-Centric approach, enabling drug developers to gain higher precision in the understanding of clinical Mode of Action (MoA), so that a drug candidate can move rapidly to clinical trials. Inoviem is accelerating and securing the entire drug development process, by incorporating clinical reality into early discovery, preclinical, and clinical drug development … Type: | 0 | 0 | 0 | 13 |
 | Feeligreen Dermo-innovation Feeligreen is a technology startup developing safe and effective micro-current devices for a wide range of cosmetic and therapeutic applications. With applications ranging from anti-ageing to wound healing, it develops and sells innovative drug-delivery systems to TIer1 pharmaceutical laboratories medical devices, therapeutics, cosmetics, and skincare Type: | 7 | 4 | 1 | 7 |
 |  Zippyware [Automatic translation follows] “Health – Education – Digital”: this is Zippyware’s leitmotif. Our mission ? Ensuring that each of us becomes an actor in our own health through interactive solutions. At Zippyware, we are convinced of the need for prevention in public health and the major role of therapeutic education, in particular through multimedia supports. Digital transformation creates tremendous opportunities to enable as many people as possible to take control of their health. Thanks to our unique combination of medical, educational and technological skills, Zippyware offers fun, innovative, efficient e-health solutions that meet the specific needs of users. Our tools … Type: | 0 | 0 | 0 | 0 |
 | NanoMedSyn NanoMedSyn develops a new delivery platform to create first-in-class drugs by the engineering with patented AMFA vectors NanoMedSyn was born from the fundamental research of its biologist and chemist founders who discovered a breakthrough technology for drug delivery to the lysosomal cell compartment leading to potentiation of therapeutics. This technology, validated at the preclinical level, has a wide range of applications in the fields of oncology, immunity, inflammation or metabolism. NanoMedSyn’s development plan is based on a strong intellectual property of patented synthetic derivatives called AMFA. The main application is the engineering of recombinant proteins like antibodies or enzymes for … Type: | 0 | 0 | 0 | 7 |
 | SYNOVANCE Engineering a Sustainable Future We are a strain development company. We engineer purpose-built secondary genomes that facilitate the bio-production of high value chemicals and enzymes. Inline with the circular economy, we are currently establishing a biorefinery that uses second generation sustainable feedstocks for fermentations. Biotechnology, Genome Engineering, Synthetic Biology, pigments, and fermentation Type: | 8 | 2 | 7 | 12 |
 | Regulaxis SAS Regenerative Medicine - Growth Disregulation - Oncology REGULAXIS is a French innovative biotechnology company based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, development and licensing of innovative synthetic molecules for use in human therapies. Its mission is to grant licenses of innovative molecules in a pharmaceutical company after the establishment of a phase II clinical record. REGULAXIS leads its R&D on its own premises, particularly in regard to biochemical and biological experiments, and keeps the mastery of the chemical synthesis of its therapeutic molecules. The company develops its … Type: | 0 | 0 | 0 | 3 |
 | MImAbs SAS Innovative start up developing monoclonal antibodies in cancer and inflammatory diseases MImAbs is an innovative start-up specialized in immunotherapy. Our goal is to develop monoclonal antibodies in cancer and inflammatory diseases for third parties (academics, pharmacuetical companies, biotechnologies, etc.) Anticorps monoclonaux, Immuno-pharmacologie, Génération et bioproduction d'anticorps, and Génération d'immunoconjugués Type: | 3 | 3 | 0 | 29 |
 | Lamina Therapeutics Developing innovative implantable medical devices for orthopaedic applications Lamina Therapeutics is a pioneering biotechnology company, developing innovative medical devices promoting patient's active live. Lamina’s technology consists of a three-dimensional biodegradable wound dressing with nano-reservoirs including active therapeutics in combination with patient’s own stem cells. This unique multifunctional approach offers a variety of potential applications addressing unmet medical needs in the field of orthopaedics, maxillofacial and periodontal lesions. Lamina’s lead product lamina.ONE, offering a hybrid therapeutic action for the repair of cartilage as well as subchondral bone for a full recovery of the articular function, is expected to enter phase I/II … Type: | 0 | 0 | 0 | 4 |
 | Healshape A regenerative medecine company Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer. Biotechnology, Regenerative medecine, Médecine régénérative, Reconstruction mammaire, Cancer du sein, Breast cancer, Breast regeneration, Breast reconstruction, 3D bioprinting, Tissue engineering, Biologie cellulaire, Impression 3D, Funds raising, and Tissue engineered products Type: | 19 | 17 | 12 | 20 |
 | Flash BioSolutions CDMO expert specialized in gene delivery Flash BioSolutions is a World-class CDMO expert in lentiviral vector manufacturing : With our continuum from research to the clinic we support you throughout your projects from R&D to GMP grade. We provide purified and highly concentrated particles from small scale to large scale with the same vector specifications. Flash BioSolutions provides integrative lentiviral vectors and RNA particles. Lentiviral vectors - LentiCare® : Conventional lentiviral vectors, which lead to DNA integrated into the genome, are a leading delivery method for applications which require a stable and long-term gene expression. Ideal for Gene Therapy and … Type: | 19 | 2 | 5 | 52 |
 | DIXI medical Designer and manufacturer of medical devices for functional and stereotactic neurosurgery for the treatment of epilepsy. DIXI medical design and manufactures medical devices for functional and stereotactic neurosurgery for the treatment of epilepsy. Epilepsy, SEEG, and Electrodes Type: | 6 | 2 | 1 | 88 |
 | Cell-Easy Your science-driven CDMO dedicated to Cell Therapy Cell Easy is a rapidly growing Contract Development and Manufacturing Services organization (CDMO) with a dedicated focus on Advanced Cell Therapies. Established in 2017, Cell Easy's commitment extends beyond development and manufacturing; it also places a strong emphasis on regulatory and analytical aspects. Cell Easy offers a comprehensive suite of services, including process development, process scale-up, cGMP manufacturing, and analytical support for immune cells (engineered CAR-T, NK cells, and non-engineered cells) as well as adult stem cells (MSCs, iPSCs, and Exosomes). Our company has achieved significant milestones, such as advancing programs to Phase … Type: | 0 | 0 | 0 | 39 |
 | ElyssaMed SAS ElyssaMed® will develop the first therapeutic treatment for clinical use comprising several antigenic peptides (epitopes) derived from CTPP and selective for non-small-cell lung cancer, combined with an already marketed vaccine adjuvant. This product once administered to lung cancer patients, will amplify the patients' specific immune responses against tumor cells expressing the antigen CTPP and lead to their destruction. Type: | 4 | 4 | 0 | 2 |
 | BrainPlotting Human PK data from preclinical stages BrainPlotting is a french contract research organization company which offers his knowledge to predict the entrance of drugs into the brain To that end BrainPlotting developped in vitro models based on fresh human tissus and cells. BrainPlotting is incubated at the Brain and Spine Institute (ICM), Paris, France Our core business is the study of pharmacokinetics (PK) in the human brain. The molecules that we study can have CNS targets as well as peripheral targets. To study the brain's PK, BrainPlotting uses the most accurate predictive models and the most recent methods and tools. … Type: | 0 | 0 | 0 | 1 |
 | SpineGuard Securing Implant Placement Making Spine Surgery Safer SpineGuard is a French innovative medical company dedicated to the deployment and adoption of DSG® (Dynamic Surgical Guidance), powerful radiation-free real time sensing technology platform that spans a broad spectrum of skeletal applications from bone drilling instruments to automated placement of bone implants. Uniquely positioned to change the game in orthopedic robotic surgery. Devices, built with the DSG technology, give real-time audio and visual feedback to the surgeons to secure and streamline skeletal implant placement for the benefit of patients, surgeons, operating room staff and healthcare providers. The PediGuard probes are the only … Type: | 1 | 0 | 1 | 30 |
 | Nextep Health Cabinet de conseil en stratégie spécialisé dans les problématiques de santé Nextep, a catalyst for ideas and expertise : "When all healthcare players want to create more value for patients " Founded in 1999, Nextep is an independent healthcare consultancy firm specialized in 6 complementary practices: Strategy & Performance; Business Development; Public Affairs & Strategic communication; Market Access & Health Economics; Training; Publishing Specialized in strategic health issues. Our interventions for customers throughout Europe and the United States are intended to support managers – from innovative SMEs to multinationals – in their development, both in medicine, biotech, the “medical device” … Type: | 17 | 3 | 14 | 51 |
 | Delaware Humane Association Founded in 1957, Delaware Humane Association (DHA) is a nonprofit no kill animal shelter and adoption center serving a four state area. We make "friends for life" by connecting people with animals, and by building strong relationships to better serve our community. We envision a day when every animal is loved, has a home, and has a "friend for life." At DHA, we make "friends for life" by: * Matching the right people with the right animals * Offering a friendly, welcoming environment * Empowering others to care for animals * Being kind, caring and compassionate Each year, hundreds of … Type: | 1 | 0 | 1 | 17 |
 | Twist Bioscience Synthetic DNA for Health & Sustainability Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise … Type: | 7 | 1 | 6 | 1,061 |
 | Daiichi Sankyo Europe GmbH Passion for Innovation. Compassion for Patients. Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - … Type: | 4 | 1 | 1 | 900 |
 | TOMZ Corporation An industry leading manufacturer of life-changing medical devices and implants. ISO 13485:2016 Certified & FDA Registered TOMZ Corporation was founded in 1988 and is a leader in the manufacturing of precision components for major medical device, healthcare and laboratory diagnostics. We have been able to maintain private ownership and operation since inception and will continue into the next generation. With 150,000+ square feet, our facilities across Connecticut and Indiana house state of the art, validated CNC Lathe/Mill/Wire EDM, Finishing, Passivation/Anodize, Inspection, to Package & Label. We are truly your "one stop shop." TOMZ understands and works closely with our customers … Type: | 0 | 0 | 0 | 129 |
 | Spexis AG Life-changing therapies for rare disease and oncology patients. Merger between EnBiotix Inc. and Polyphor AG. Spexis AG (SIX:SPEX) is a publicly-listed Swiss clinical-stage biopharmaceutical company developing rare disease and oncology treatments in indications where new therapeutic options are urgently needed. Spexis AG was launched in December 2021 by the reverse merger of EnBiotix, Inc. (Boston, MA, USA) and Polyphor AG (Allschwil, Switzerland), with EnBiotix shareholders resulting in the majority. Our focus is on chronic respiratory diseases (CRD), and our lead product candidate ColiFin® is P3 ready. ColiFin® is an inhaled colistimethate sodium product in-licensed from PARI Pharma GmbH for ex-European … Type: | 0 | 0 | 0 | 27 |
 | Sequana Medical NV Pioneers in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer Sequana Medical NV is a pioneer in treating drug-resistant fluid overload, a serious and frequent clinical complication in patients with liver disease, heart failure and cancer. Fluid overload is a well-recognized problem in these growing diseases, causing severe problems for the large number of patients for whom current medicines are no longer effective. These patients can have up to 15 liters of extra fluid in their bodies, causing major medical issues including increased mortality, repeated hospitalizations, severe pain, difficult breathing and restricted mobility that severely … Type: | 0 | 0 | 0 | 67 |
 | Oryzon Genomics SA Pioneering personalized medicine in epigenetics Oryzon Genomics, S.A. is a clinical stage biopharmaceutical company and the European leader in the development of epigenetics-based therapeutics, with a strong focus on personalized medicine approaches to CNS disorders and oncology. Oryzon has a broad and growing portfolio, with two compounds in clinical trials: iadademstat, a highly potent and selective LSD1 inhibitor, in Phase IIa clinical trials for the treatment of acute myeloid leukemia and small cell lung cancer, and vafidemstat, a CNS optimized LSD1 inhibitor in multiple Phase II trials for the treatment of CNS and psychiatric diseases. Phase IIb trials for both … Type: | 0 | 0 | 0 | 58 |
 | Immatics Delivering the Power of T Cells to Cancer Patients Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer. Read more about Immatics on our homepage: … Type: | 1 | 1 | 0 | 467 |
 | Compugen A clinical-stage cancer immunotherapy company and a pioneer in computational target discovery Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify new drug targets and biological pathways for developing cancer immunotherapies. Compugen has developed two proprietary product candidates: COM701, a potential first-in-class anti-PVRIG antibody and COM902, a potential best-in-class antibody targeting TIGIT for the treatment of solid tumors. Compugen also has a clinical stage partnered program, rilvegostomig (previously AZD2936), a PD-1/TIGIT bispecific antibody where the TIGIT component is derived from Compugen’s clinical stage anti-TIGIT antibody, COM902, in Phase 3 development … Type: | 11 | 1 | 10 | 101 |
 | Chittick Family Eye Care The Doctors and Staff of Chittick Family Eye Care strive to provide each patient with excellence in vision and eye health care. We guarantee our constant commitment to the visual wellness of our patients by extending thorough diagnostic and therapeutic eye care, by emphasizing personalized service, and by never compromising materials, value, or professionalism Chittick Family Eye Care provides superb care for your eyes. From contacts, glasses and LASIK consultation to pediatric eye care, cataracts and vision therapy, we provide comprehensive care for the eye care of your entire family. Optometry, Contact Lenses, Eye Disease Prevention and Management, Eye Examinations, … Type: | 0 | 0 | 0 | 40 |
 | Akin (formerly Children's Home Society of Washington) Our Purpose:We work to disrupt systemic and multi-generational cycles of inequity by partnering with children, families Children's Home Society of Washington and Childhaven, have merged to become Akin. This merger allows us to grow and evolve as one organization, not for the sake of size but for the scope of direct impact in our commitment and partnership to and for children, families and communities. Visit us at our new website: www.akinfamily.org. early learning, family support programs, child and family counseling, therapeutic foster care, adoption services, search and reunion, advocacy for children, and Wendy's Wonderful Kids Type: | 2 | 0 | 2 | 244 |
 | CYRANIE NUTRITION [Automatic translation follows] For 20 years, Cyranie has made taste its central concern, our very diverse products adapt to everyone's appetites and requirements and promote the pleasure of eating. Cyranie develops, manufactures and markets a range of dehydrated food mixes. Cyranie has always based its approach on taste and nutritional qualities while respecting tradition and French culinary know-how. We are manufacturers, our products are exclusive and developed by our R&D department in close collaboration with our customers. Cyranie has veterinary approval, works according to the HACCP method and since 2014 has obtained IFS v6 superior certification guaranteeing the quality and … Type: | 3 | 1 | 2 | 7 |
 | Mission Therapeutics Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential ‘Next Kinase Area’. Mission’s DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas. Mission’s strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially … Type: | 6 | 2 | 5 | 37 |
 | My Muscle Chef Voted Australia’s best meal delivery service 7 years running, with 100+ high protein fresh meals, snacks +drinks. My Muscle Chef has been fuelling professional athletes and active Australians since 2013 with our award winning, dietitian designed, chef-prepared meals, snacks and drinks. We produce in excess of 2.2 million fresh meals, snacks and drinks for the Australian market each week for delivery to customers' doors and to 6,000+ retail stockists. My Muscle Chef is all about offering smart nutrition that enables you to feel your best. We pair high-quality meals with exceptional taste with the ultimate convenience and ease, allowing you … Type: | 1 | 0 | 1 | 208 |
 | Healx AI-powered and patient-inspired. We accelerate the discovery and development of rare disease treatments. Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this … Type: | 1 | 0 | 1 | 71 |
 | SureChill SureChill is an innovative, once in a generation cooling technology SureChill is a pioneering platform cooling technology that continuously cools for weeks without power. It is innovative and its performance is unrivalled. By harnessing the unique properties of water, it allows continual cooling at a perfect 4oC, anywhere in the world. The technology is saving lives today, and it can help save our planet. Vaccine Refrigerators powered by SureChill technology were first launched into the medical market in 2011, far exceeding the most stringent standards set by the World Health Organization. Today, they’re purchased by the likes of UNICEF, saving … Type: | 0 | 0 | 0 | 36 |
 | DNANUDGE Nudging your everyday choices through your DNA plus your lifestyle. Buy in-store and online now. DnaNudge is the developer of the world’s first service to use consumers’ own DNA plus lifestyle factors to nudge people towards healthier choices while shopping. The DnaNudge service analyses and maps users’ genetic profile to key nutrition-related health traits such as obesity, diabetes, hypertension and cholesterol, enabling customers to be guided by their DNA towards healthier eating. The service has been developed by world-renowned biomedical engineer Regius Professor Chris Toumazou FRS and published geneticist Dr Maria Karvela. This ground-breaking in-store DNA testing service created to … Type: | 5 | 1 | 3 | 56 |
 | Roche Diabetes Care #ConnectingWhatCounts For over 125 years, Roche has taken on some of healthcare’s greatest challenges by listening and responding to the ever-changing needs of people around the world. One of today’s most urgent and complicated challenges is the global diabetes epidemic. With almost 50 years of experience in the diabetes care space and with 4,500 employees in more than 100 countries, we continue to focus on everyday support to help people with diabetes find true relief, no matter where they live. With our Accu-Chek and mySugr brands, we offer one of the most comprehensive portfolios of diabetes management products and services … Type: | 3 | 1 | 2 | 293 |
 | INFEX Therapeutics Vital new drugs for pandemic infections We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections. Pharmaceuticals, R&D, Antimicrobial Resistance, and Development Type: | 3 | 0 | 0 | 21 |
 | BePharBel Manufacturing SA HELPING CREATE A HEALTHIER WORLD THROUGH EXCELLENCE As CDMO (Contract and Development Manufacturing Organization), BePharBel Manufacturing contributes to improve the health of all by supplying our pharma partners: - a genuine end-to-end development and manufacturing solution - that facilitates and accelerates drugs availability for patients. Our main activities are: 1) CDMO BePharBel Manufacturing provides an integrated end-to-end solution for the development and manufacturing, under European GMP conditions, of drugs (small molecules and antibiotics) and medical devices. Our expertise field is the development of new formulations and drug formulations over more than 10 different sterile and non-sterile galenic forms (injectables, powder … Type: | 0 | 0 | 0 | 89 |
 | GoodGut Enhancing digestive health GoodGut is a biotechnology company focused on researching and developing analysis systems and therapeutic products to improve the diagnosis and treatment of digestive diseases based on intestinal microbiota. We aim to provide technological tools that will help to obtain a faster, more reliable and lower cost medical diagnosis than existing methods, alongside therapies to improve the quality of life of patients with compromised digestive health. The company was created in 2014 as a spin-off of the University of Girona (UdG) and the Institute of Biomedical Research of Girona Dr. Josep Trueta (IdIBGi). Our facilities can be found … Type: | 4 | 1 | 2 | 15 |
 | 3Biotech 3Biotech provides Innovative solutions continuously to create a new future and impact patient outcomes 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidate. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Three Pillars; Safety, Efficacy, Manufacturing are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan to execution More, we have implemented a human and customer centric organization to … Type: | 2 | 1 | 2 | 4 |
 | Osivax Pioneering A New Class of Universal Vaccines Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM®, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company … Tags: FrenchTech2030 Type: | 22 | 11 | 13 | 53 |
 | ADEXSOL Adexsol is a consulting and training company based in Paris that provides healthcare companies and institutions with knowledge of the goals, organisation and functioning of the French healthcare system. Adexsol can help you with: - Better understanding and analysing needs of the hospital and healthcare world in order to build an offer meeting key players’ needs. - Setting up training for industry sales forces and managers on topics related to organisation and functioning of the hospital. - Carrying out market research, polls and opinion trackers. - Organising events nationally or regionally: conferences, workshops, seminars, and scientific boards. - Developing your … Type: | 4 | 0 | 2 | 2 |
 | ELSALYS BIOTECH Innovative medicines to address haemato-oncology related life-threatening and rare diseases ElsaLys Biotech is a specialty pharmaceutical company, part of the Mediolanum Farmaceutici Spa group, focused on innovative medicines to address haemato-oncology related life-threatening and rare diseases. Following strategic acquisitions and targeted developments, ElsaLys is establishing an immunotherapeutic portfolio focused on niche specialty pharmaceuticals to answer unmet medical needs. Our commitment is to offer essential drugs meeting Public Health needs. Founded in 2013, ElsaLys Biotech is located in the heart of the European cluster Lyon Biopole, in Lyon, France. Anticorps thérapeutiques, Anticorps monoclonaux, Therapeutic antibodies, Monoclonal antibodies, ophtalmologie, immune microenvironment, vascular … Type: | 7 | 3 | 1 | 1 |
 | Aliri We deliver data for life > Aliri is committed to solving industry challenges by bringing innovative bioanalysis and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions. MALDI Imaging, ADME analysis, Mass Spectrometry Imaging, Preclinical services, Molecular Imaging, Biodistribution, … Type: | 8 | 5 | 3 | 154 |
 | SLS France [Automatic translation follows] SLS France is a company being created in the Rennes area. This structure will allow the manufacture of chrome-cobalt dental prostheses by micro-fusion. Based on a multidisciplinary team competent in this technology, our desire is to offer a quality product that perfectly meets the needs of our future customers. Type: | 3 | 0 | 0 | 17 |
 | Unooc [Automatic translation follows] The ambition of the Unooc.fr site is to support pharmacists on the Internet and to guarantee Internet users a purchase from a French pharmacy approved by the government. + For pharmacists: increased visibility, geolocation, highlighting their advice and offers. + For French people: buy safely and at the best price. In one click, Unooc allows you to find: - Drugs, - Homeopathy, - Beauty products, - Baby products, etc. More than 50,000 references from around fifty French partner pharmacies. http://www.Unooc.fr/ Health, Internet, E-Commerce, and Search Engine Type: | 1 | 1 | 0 | 1 |
 | Happineo [Automatic translation follows] A psychologist who understands you, anywhere, anytime Happineo offers consultations from qualified psychologists from home by telephone and messages. Confidential and simple, our service allows you to start quality therapeutic monitoring very quickly. Health, Well-being, Psychology, occupational health, and psychosocial risks Type: | 0 | 0 | 0 | 1 |
 | eVeDrug [Automatic translation follows] eVeDrug calls on different stakeholders all linked to the field of Pharmacovigilance: professionals from the pharmaceutical industry and scientists who have pooled their know-how, and with their experience acquired both from industrial environments (laboratories and manufacturers ) as well as Institutional environments (health authorities in different countries). eVeDrug wishes above all to restore trust between patients and their health system by placing the main interested party (the patient themselves) at the center of the health system responsible for protecting them. Thus, eVeDrug distributes the free My eReport application which allows any person (patient, relative, health professional, etc.) … Type: | 12 | 2 | 5 | 7 |
 | CellProthera SAS Pionnier de la thérapie régénératrice cardiaque CellProthera, a biotechnological company, has developed a unique therapeutic technique which enables the structural and functional regeneration of severe post-infarctus cardiac lesions. After European and national (FR/GB) authorization was obtained , CellProthera has started its I/IIB clinical trial in Humans. Heart Regeneration Type: | 13 | 6 | 6 | 32 |
 | Wandercraft Ordinary life for Extraordinary people We're hiring ! https://wandercraft.welcomekit.co/ Wandercraft ‘s job is to make wheelchair users walk again. We make real the promises of robotics by providing an ordinary life to extraordinary people. We have developed the first autonomous exo. In our world premiere clinical trials, persons with paraplegia walked human-like, autonomously and without crutches. The Wanderteam walks on the edge of robotics. We cooperate with world class university labs and medical centers in Europe and the US. Atalante is not only an exoskeleton. Atalante allows patients to stand up, without crutches. Atalante allows patients to finally be able … Tags: FrenchTech2030 Type: | 37 | 17 | 19 | 125 |
 | Bcell Design Best-in-class monoclonal antibodies with Human Fc Based in Illkirch-Graffenstaden (France), Bcell Design is a monoclonal design expert. The company has developed unique technologies to produce human Fc monoclonal antibodies with excellent reactivity. 1/ IVD Our high-quality monoclonal antibodies are specifically designed for in vitro diagnostics. They are used for positive controls, calibrators and quality controls. Some products have been tested and found reactive in DiaSorin LIAISON XL assays, BioMérieux Vidas, bioVendor KleeYa system etc... Our products are included in manual and automatic kits, under IVDR and FDA regulations. They are used as a quality control tool for all types of … Type: | 3 | 2 | 3 | 6 |
 | ENYO Pharma Developing therapeutics for diseases with impaired kidney function ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor. Type: | 8 | 3 | 5 | 31 |
 | Beta Innov [Automatic translation follows] Development of innovative drugs with curative potential in Immunology and Cancerology. Beta Innov SAS is an innovative pharmaceutical Research and Development company, created in March 2009 by patient families. Beta Innov aims to achieve a major therapeutic leap in the treatment of autoimmune diseases and Glioblastoma by using a physiological (Immunology) or metabolic (Glioblastoma) approach avoiding the costs of gene therapies and the adverse effects of therapies. by antibodies. Type: | 0 | 0 | 0 | 14 |
 | Sinnovial SAS [Automatic translation follows] Sinnotest® supports rheumatologists in optimizing the prescription of biotherapies in rheumatology SINNOVIAL is a biotechnology company that develops personalized medicine devices to improve the management of Chronic Inflammatory Rheumatism (RIC) in Rheumatology (rheumatoid arthritis, ankylosing spondylitis, in particular). Our mission: to improve the quality of life of patients by maximizing the chances of success of their treatment with biotherapy. Our objective: to provide the doctor with a device to assist in therapeutic orientation which allows him, in real time, to optimize the selection of biotherapy. “The right treatment, to the right patient, at the right time!” » … Type: | 2 | 1 | 1 | 4 |
 | Gecko Biomedical Gecko Biomedical is a fast-paced medical device company, dedicated to the development of innovative tissue reconstruction solutions. We are leveraging our technology platforms to develop novel solutions to disrupt the field of surgery and positively impact the life of patients. Type: | 0 | 0 | 0 | 4 |
 | PHARNEXT New therapies for neurodegenerative diseases Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases that currently lack curative and/or disease-modifying treatments. Pharnext has two lead products in clinical development. PXT3003 completed an international Phase III trial with positive topline results for the treatment of Charcot-Marie-Tooth disease type 1A (‘CMT1A’) and benefits from orphan drug status in Europe and the United States. An international pivotal Phase III study of PXT3003 in CMT1A, the PREMIER trial, is currently ongoing. PXT864 has generated encouraging Phase II results in Alzheimer’s disease and will be advanced through partnerships. Both of Pharnext’s … Type: | 2 | 1 | 2 | 30 |
 | CERTIS Therapeutics Disruptive solutions for image guided therapies Certis Therapeutics develops and markets minimally invasive thermo-ablation solutions. These solutions are controlled by real time MRI images including accurate 3D temperature maps and deliver treatments for cardiological, oncological and neurological diseases. The company aims at providing best in class solutions delivering significantly higher efficacy and safety as to current standards of care. medical device, oncology, cardiology, MRI guided, and Thermal ablation Type: | 3 | 3 | 0 | 18 |
 | Corlieve Therapeutics At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurological disorders. Corlieve Therapeutics, a fully owned subsidiary of UniQure, is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders. Type: | 2 | 2 | 0 | 3 |
 | BIOTIS Bordeaux Laboratory for the Bioengineering of Tissues (Mixed Research Unit: Inserm and Bordeaux University) The BioTis laboratory (Laboratoire de Bioingénierie Tissulaire – Laboratory for the Bioengineering of Tissues) is a “Mixed Research Unit” (#1026) that is comprised of personnel from the INSERM, the French national institute of health and medical research), and from the University of Bordeaux. The Unit is located on the 5th floor of the new Bordeaux Biologie Santé (BBS) building at the University of Bordeaux medical campus. BioTis has around 65 members including full time researchers, junior and senior professors in medicine/medical sciences, technical and support staff, post-doc … Type: | 1 | 1 | 0 | 21 |
 | Emopsy [Automatic translation follows] By mixing the scientific and the clinical, emopsy offers new tools for evaluating and supporting emotional skills for psychologists. Type: | 12 | 2 | 0 | 2 |
 | BoneTag Reinventing orthopedics BoneTag is a french start-up, based in Montpellier, which is focused on the development of innovative medical devices in orthopedics. BoneTag is developing two medical devices: • INCESSU: A solution making total knee arthroplasties (TKA) smart and connected. This medical device allows the communication between the implanted TKA and the surgeon. The communicated data are: identification information about the TKA, temperature in contact with the bone and motion between the TKA and the bones. • KNEEMATICS: A dynamic 3D representation of the kinematics of total knee arthoplasties. This device allows the visualization in real-time, and in 3D, of … Type: | 1 | 1 | 0 | 5 |
 | MAAsiRNA MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). A significant challenge in the field of nervous system pathologies lies in the absence of effective treatments. MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). After over a decade of intensive interdisciplinary research, we have successfully developed a siRNA-based treatment for Charcot-Marie-Tooth disease type 1A (CMT1A), the most prevalent form of hereditary peripheral neuropathy. CMT1A affects 1 in 5000 people, comprising a total of 1.5 million individuals worldwide. Our current objective is to advance towards a patient-ready therapy. Our innovative therapeutic approach has the potential to … Type: | 1 | 1 | 0 | 3 |
 | Blue Bees Therapeutics Blue Bees Therapeutics develops immunomodulatory proteins with therapeutic potential to fight cancer Blue Bees Therapeutics is a biotechnology company founded in March 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancers, based on a breakthrough technology discovered by the team led by Dr Michel Léonetti, within the Department of Pharmacology and Immunoanalysis from CEA Paris-Saclay. This technology allows to generate antibodies stimulating the anti-tumor immune response via a double cell receptor targeting coupled with heparan sulphate proteoglycans (HSPG). Immunothérapie, Immuno-oncologie, pharma, Biotech, Immunologie, Oncologie, Cancer, Médicament, and Drug Type: | 2 | 2 | 0 | 8 |
 | Diotheris Diotheris develops anti-infective microbes to prevent bacterial infections and act against antibiotic resistance We create bacterial therapies of the human skin and mucosal microbiome against pathogenic bacteria. Our first suite of products (NASOFLORE line) targets Staphyloccocus aureus / MRSA (Methicillin resistant S aureus). The products based on live bacteria identified in our clinical and in vitro studies do not generate emergence of antibiotic resistance. antimicrobial, nose microbiome, therapeutics, LBP, Staphylococcus Aureus, and MRSA Type: | 1 | 1 | 0 | 1 |
 | Deeptope Advanced Antibody Expertise Deeptope's expertise lies in antibody charaterisation (epitope/paratope mapping) and optimisation using high throughput methods. antibody, paratope mapping, epitope mapping, and antibody optimisation Type: | 1 | 1 | 0 | 7 |
 | Kimialys Innovative biosensing solutions for diagnostic and pharmaceutical companies, leveraging our K-One® surface chemistry. We are a team of chemists and biosensor engineers gathered around a common mission: shaping the future of biodetection for a better world. Kimialys is the result of 10 years of meticulous academic research in surface chemistry. Controlling what is happening on the surface is a fundamental aspect of biosensing techniques such as rapid tests, point-of-care diagnostics, and real-time sensors. Without the right surface interactions, even the most advanced biosensors can falter, leading to misleading results. Our research efforts have always been to optimize these crucial parameters, … Type: | 7 | 4 | 2 | 15 |
 | Sirius NeoSight [Automatic translation follows] New view for cancer therapeutics Sirius NeoSight is an innovative technological breakthrough company which aims to become a key player in the detection of subclinical neo-cancers, relapses and therapeutic monitoring of patients, thus offering doctors a new perspective on the therapeutic effectiveness implemented. . Sirius NeoSight uses breakthrough patented technology from a consortium of academic laboratories with expertise in the field. Type: | 14 | 4 | 6 | 4 |
 | EYE TECH CARE Ultrasound Cyclo Plasty = Focused, Adaptable, Proven EYE TECH CARE, based in Lyon, was founded in 2008 by experts in the field of therapeutic ultrasound. The company develops and markets medical devices for the non invasive treatment of eye diseases. Glaucoma and ocular hypertension affect some 12O million people around the world, but are diagnosed in only about 30% of cases. It is the second cause of blindness, according to WHO (World Health Organization). With the support of renowned scientific and financial partners, EYE TECH CARE has developed the EyeOP1, an unique therapeutic device. Its teams have designed the only … Type: | 2 | 2 | 0 | 30 |
 | Oncofactory 🖇️ Oncofactory, a spin-off of the CNRS, is a science-driven biotech company that provides pharmaceutical and biotech companies with innovative in vivo services to support their non-clinical programs in oncology. Oncofactory joined the ERBC Group in December 2022 to extend its technology to a wider range of customers and provide a one-stop shop for non-clinical studies. 🥚Oncofactory unique technology platform is a New Approach Methodology (NAM) to generate patient tumor replicas in avian embryos (AVI-PDXTM), coupled with state-of-the-art 3D imaging and large-scale molecular analysis for rapid assessment of therapeutic efficacy and in-depth characterization of mechanisms of action to evaluate therapeutic … Type: | 3 | 1 | 2 | 8 |
 | Laboratoire de Biologie Tissulaire et Ingénierie thérapeutique (LBTI) Explore Understand Innovate LBTI is a leading French research laboratory specializing in the study of healthy and diseased tissues and in the development of innovative therapeutic strategies with high potential for translation toward clinical applications. We have strong expertise in human skin, cartilage and mucosae. Our specific research aims are: > to analyze the basic mechanisms of tissue organization and homeostasis, and to identify potential therapeutic targets > to understand and model the tissue response to physiological or pathological stress (including mechanical stress and aging) > to develop novel therapeutic approaches for tissue repair and targeted delivery of therapeutic agents … Type: | 3 | 2 | 1 | 43 |
 | DimiCare Biotech goes FAR BEYOND (Fighting Antimicrobial Resistance to the Biological EmergencY to Opportunistic and Neglected Diseases) Dimicare Biotech is a project from INSERM and Université Côte d'Azur focused on the development of novel "precision" antimicrobial drugs to fight multidrug-resistant infections. Our main project focuses on the development of a new treatment against multidrug-resistant S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus strains). Currently, this treatment is in the early-preclinical phase where its efficacity against several clinical strains and its innocuity in Human cells has been confirmed. Dimicare Biotech is building a great team involving Microbiology Medical doctors, Fundamental … Type: | 7 | 2 | 0 | N/A |
 | NERVOSAVE THERAPEUTICS Innovative therapies for peripheral nerve diseases Nervosave Therapeutics discovers and develops therapies that slow, stop and reverse a broad range of demyelinating peripheral nerve diseases. Our first aim is to develop best in class Gene Therapy for CMT1A patients and beyond for all demyelinating CMT diseases. We develop robust discovery programs targeting both CMT diseases and acquired demyelinating peripheral neuropathies such as diabetic peripheral neuropathy and Guillain-Barré syndrome. Type: | 3 | 1 | 0 | 4 |
 | Stent Up Stent'Up vise à sécuriser le traitement préventif des anévrismes cérébraux par la création d'un implant révolutionnaire. Stent Up, designs, manufactures, and markets medical devices dedicated to the treatment of strokes. Type: | 8 | 1 | 7 | 6 |
 | Catsalyze We improve your enzymes. Catsalyze will revolutionize enzymatic biocatalyze. Our proprietary technology allows us to graft enzymes around a protein ring, which gives them strong advantages such as increased stability, solubility, efficiency but also the possibility of assembling these grafted rings to create perfectly colocalized enzymatic cascades. . So extremely effective. Our challenge? Transform biomass in a gentle and clean way and through accelullar enzymatic catalysis into chemical bricks classically petrosourced and synthesized with pollution. The future of chemistry passes through Catsalyze. Type: | 25 | 4 | 22 | 2 |
 | Cell&Soft Soft culture plates for pleased cells Cell&Soft is a young french biotech located in the AURA region, in Grenoble city. Born from a joint project between LTM Lab (CNRS) and CEA BIG, Cell&Soft is specialized in the development, production and sale of soft and biomechanical substrates for in vitro cell culture. Cell&Soft offers solutions to enhance the physiology and the relevance of cell culture and cell-based assays. biotechnology, cell culture, soft substrates, culture plates, cell-based assays, biotech, in vitro, drug discovery, stem cells, controlled rigidity, controlled stiffness, and petri dish Type: | 4 | 3 | 1 | 5 |
 | DreaminzZz With HYPNOS, we have created the no medical drugs therapy of the future, to get rid of medical drugs like sleeping pills You can discover HYPNOS, the first hypnotic mask connected to an application. This innovative project, Made in France, puts hypnosis available to everyone in order to contribute to our wellbeing. Thanks to HYPNOS, you can improve your sleep, handle your daily stress, reduce your pain and improve your motivation. Behind this incredible project, there are 2 mens : Kevin Kastelnik and Guillaume Gautier. Kevin is engineer and crazy about new technology and Guillaume is Practitioner of Ericksonian Hypnosis. … Type: | 3 | 2 | 1 | 9 |
 | Diamidex Make Visible the Invisible Faster to Make your World Safer Founded in 2014, DIAMIDEX (Diagnostic Microbiology Express) is an innovative company specialized in the detection and quantification of microorganisms of interest. Its mission: making the invisible visible faster, to make your world safer. Its patented innovative technological approach brings about a major breakthrough to meet the speed and technicality challenges arising from microbiological culture. Based on a powerful technological platform, recognized by the scientific and industrial communities, DIAMIDEX offers and develops turnkey test solutions, which can be used in both laboratories and in the field to obtain a quantitative count … Type: | 12 | 6 | 8 | 25 |
 | Pili carbon conscious color company Pili, carbon conscious color company Pili is the leader in bio-based colorants and pigments. Its unique fermentation and sustainable chemistry processes, enable the production of high-performance, and low-carbon colors. Its technology aims at decarbonizing the color industry by drastically reducing the use of chemicals and fossil resources, particularly oil. Its products are designed for the textile, inks, paints & coatings and plastics sectors. Founded in 2015, Pili operates from 3 different sites: Toulouse White Biotechnology (TWB), Paris and the Roches-Roussillon industrial platform in Isère. With around 40 employees to date, the company has invested over €35 … Type: | 17 | 10 | 8 | 52 |
Startup